391
Views
4
CrossRef citations to date
0
Altmetric
Psoriasis and atopic dermatitis

Comparing the effects of proactive treatment with tacrolimus ointment and mometasone furoate on the epidermal barrier structure and ceramide levels of patients with atopic dermatitis

, , , &
Pages 721-729 | Received 25 Oct 2019, Accepted 19 Dec 2019, Published online: 03 Jan 2020

References

  • Sahle FF, Gebre-Mariam T, Dobner B, et al. Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy. Skin Pharmacol Physiol. 2015;28(1):42–55.
  • Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–1072.
  • Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018;67(1):3–11.
  • Feingold KR, Elias PM. Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim Biophys Acta. 2014;1841(3):280–294.
  • Jungersted JM, Agner T. Eczema and ceramides: an update. Contact Dermatitis. 2013;69(2):65–71.
  • Jungersted JM, Hellgren LI, Jemec GB, et al. Lipids and skin barrier function–a clinical perspective. Contact Dermatitis. 2008;58(5):255–262.
  • Holleran WM, Takagi Y, Uchida Y. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Letters. 2006;580(23):5456–5466.
  • van Smeden J, Bouwstra JA. Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr Probl Dermatol. 2016;49:8–26.
  • Janssens M, van Smeden J, Gooris GS, et al. Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J Invest Dermatol. 2011;131(10):2136–2138.
  • Imokawa G, Abe A, Jin K, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol. 1991;96(4):523–526.
  • van Smeden J, Janssens M, Kaye EC, et al. The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients. Exp Dermatol . 2014;23(1):45–52.
  • Ishikawa J, Narita H, Kondo N, et al. Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol. 2010;130(10):2511–2514.
  • Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol. 2002;119(1):166–173.
  • Bleck O, Abeck D, Ring J, et al. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J Invest Dermatol. 1999;113(6):894–900.
  • Janssens M, van Smeden J, Gooris GS, et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res. 2012;53(12):2755–2766.
  • Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284–1293.
  • Kezic S, Novak N, Jakasa I, et al. Skin barrier in atopic dermatitis. Front Biosci. 2014;19(3):542–556.
  • Jungersted JM, Hellgren LI, Drachmann T, et al. Validation of cyanoacrylate method for collection of stratum corneum in human skin for lipid analysis. Skin Pharmacol Physiol. 2010;23(2):62–67.
  • Roduit C, Frei R, and the PASTURE study group, et al. Phenotypes of atopic dermatitis depending on the timing of onset and progression in childhood. JAMA Pediatr. 2017;171(7):655–662.
  • Simpson EL, Guttman-Yassky E, Margolis DJ, et al. Association of inadequately controlled disease and disease severity with patient-reported disease burden in adults with atopic dermatitis. JAMA Dermatol. 2018;154(8):903–912.
  • Machado M, Salgado TM, Hadgraft J, et al. The relationship between transepidermal water loss and skin permeability. Int J Pharm. 2010;384(1-2):73–77.
  • Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet . 2006;38(4):441–446.
  • Jungersted JM, Scheer H, Mempel M, et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy. 2010;65(7):911–918.
  • Wollenberg A, Barbarot S, the European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682.
  • Chittock J, Brown K, Cork MJ, et al. Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis. Acta Derm Venerol. 2015;95(6):653–658.
  • Dähnhardt-Pfeiffer S, Dähnhardt D, Buchner M, et al. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis. J Dtsch Dermatol Ges. 2013;11:437–443.
  • Blaak J, Dähnhardt D, Dähnhardt-Pfeiffer S, et al. A plant oil-containing pH 4 emulsion improves epidermal barrier structure and enhances ceramide levels in aged skin. Int J Cosmet Sci. 2017;39(3):284–291.
  • Daehnhardt-Pfeiffer S, Surber C, Wilhelm KP, et al. Noninvasive stratum corneum sampling and electron microscopical examination of skin barrier integrity: pilot study with a topical glycerin formulation for atopic dermatitis. Skin Pharmacol Physiol. 2012;25(3):155–161.
  • Dähnhardt D, Surber C, Dähnhardt-Pfeiffer S. Influence of Topical Formulations: Lipid Lamella Organization and Lipid Composition of Stratum Corneum as a Surrogate Marker for Barrier Integrity. Curr Probl Dermatol. 2018;54:166–172.
  • Kilic A, Masur C, Reich H, et al. Skin acidification with a water-in-oil emulsion (pH 4) restores disrupted epidermal barrier and improves structure of lipid lamellae in the elderly. J Dermatol . 2019;46(6):457–465.
  • Fölster-Holst R, Dähnhardt-Pfeiffer S, Dähnhardt D, et al. The role of skin barrier function in atopic dermatitis: an update. Expert Rev Dermatol. 2012;7(3):247–257.
  • Khan AM, Khondker L, Afroze D. Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis. J Pak Assoc Derma. 2014;24:57–62.
  • Danby SG, Chittock J, Brown K, et al. The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis. Br J Dermatol. 2014;170(4):914–921.
  • Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol. 1992;26(3):387–396.
  • Matsumoto T, Yuasa H, Kai R, et al. Skin capacitance in normal and atopic infants, and effects of moisturizers on atopic skin. J Dermatol. 2007;34(7):447–450.
  • Kottner J, Lichterfeld A, Blume-Peytavi U. Transepidermal water loss in young and aged healthy humans: a systematic review and meta-analysis. Arch Dermatol Res. 2013;305(4):315–323.
  • Jensen JM, Pfeiffer S, Witt M, et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol. 2009;123(5):1124–1133.
  • Di Nardo A, Wertz P, Giannetti A, et al. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol. 1998;78(1):27–30.
  • Norlen L. Skin barrier structure and function: the single gel phase model. J Invest Dermatol. 2001;117:830–836.
  • Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4:771–788.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.